Patents by Inventor Hansjoerg Schild

Hansjoerg Schild has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150344531
    Abstract: The medicament for the prevention or the relief of poisoning by large clostridial cytotoxins (LCTs), in particular Clostridium difficile toxins A and B (TcdA and TcdB), is characterized by containing as active ingredient at least one effector, namely an inhibitor or activator of the autocatalytic protease activity of LCTs (large clostridial cytotoxins).
    Type: Application
    Filed: May 29, 2015
    Publication date: December 3, 2015
    Inventors: Christoph von Eichel-Streiber, Jessica REINEKE, Stefan TENZER, Hansjoerg SCHILD, Maja RUPNIK
  • Patent number: 9066961
    Abstract: The medicament for the prevention or the relief of poisoning by large clostridial cytotoxins (LCTs), in particular Clostridium difficile toxins A and B (TcdA and TcdB), is characterized by containing as active ingredient at least one effector, namely an inhibitor or activator of the autocatalytic protease activity of LCTs (large clostridial cytotoxins).
    Type: Grant
    Filed: May 30, 2012
    Date of Patent: June 30, 2015
    Assignee: JOHANNES GUTENBERG-UNIVERSITAET MAINZ
    Inventors: Christoph Von Eichelstreiber, Jessica Reineke, Stefan Tenzer, Hansjoerg Schild, Maja Rupnik
  • Patent number: 9017654
    Abstract: The present invention relates to a pharmaceutical preparation, comprising at least one Toll-like receptor ligand and at least one peptide. The invention also relates to the use of such a pharmaceutical preparation and to a vaccination method.
    Type: Grant
    Filed: October 6, 2005
    Date of Patent: April 28, 2015
    Assignee: Johannes-Gutenberg-Universitaet Mainz
    Inventors: Hansjoerg Schild, Tobias Warger, Markus Radsak, Gerd Rechtsteiner
  • Publication number: 20130280286
    Abstract: The medicament for the prevention or the relief of poisoning by large clostridial cytotoxins (LCTs), in particular Clostridium difficile toxins A and B (TcdA and TcdB), is characterized by containing as active ingredient at least one effector, namely an inhibitor or activator of the autocatalytic protease activity of LCTs (large clostridial cytotoxins).
    Type: Application
    Filed: May 30, 2012
    Publication date: October 24, 2013
    Applicant: JOHANNES GUTENBERG-UNIVERSITAET MAINZ
    Inventors: Christoph VON EICHEL-STREIBER, Jessica REINEKE, Stefan TENZER, Hansjörg SCHILD, Maja RUPNIK
  • Publication number: 20090311258
    Abstract: The medicament for the prevention or the relief of poisoning by large clostridial cytotoxins (LCTs), in particular Clostridium difficile toxins A and B (TcdA and TcdB), is characterized by containing as active ingredient at least one effector, namely an inhibitor or activator of the autocatalytic protease activity of LCTs (large clostridial cytotoxins).
    Type: Application
    Filed: May 26, 2007
    Publication date: December 17, 2009
    Applicant: JOHANNES GUTENBERG-UNIVERSITAET MAINZ
    Inventors: Christoph Von Eichelstreiber, Jessica Reineke, Stefan Tenzer, Hansjoerg Schild, Maja Rupnik
  • Publication number: 20080193487
    Abstract: The present invention relates to a pharmaceutical preparation, comprising at least one Toll-like receptor ligand and at least one peptide. The invention also relates to the use of such a pharmaceutical preparation and to a vaccination method.
    Type: Application
    Filed: October 6, 2005
    Publication date: August 14, 2008
    Applicant: Johannes-Gutenberg-Universitaet Mainz
    Inventors: Hansjoerg Schild, Tobias Warger, Markus Radsak, Gerd Rechtsteiner